Skip to main content
DNA Labs India

MMAA Gene Methylmalonic aciduria CblA type NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MMAA Gene Methylmalonic aciduria CblA type NGS Genetic Test

Short Name: MMAA Gene Test

Also known as: CblA type MMA, MMAA Deficiency, Methylmalonic acidemia CblA type

MMAA Gene Methylmalonic aciduria CblA type NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify mutations in the MMAA gene responsible for CblA type methylmalonic aciduria. It aids in confirming diagnosis, determining carrier status, facilitating genetic counselling, and informing treatment decisions for patients with suspected or confirmed MMA.

Test Code
2165
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Patient should provide detailed clinical history, including family pedigree, and undergo a genetic counselling session to discuss the test implications and obtain informed consent.

Method: Venipuncture or Finger prick

Step 2

Laboratory Analysis

A blood sample is collected by a trained phlebotomist using sterile techniques, either via venipuncture or finger prick for one-drop blood on FTA card.

Step 3

Report Delivery

The sample is properly labeled, stored at ambient room temperature, and transported to the laboratory under controlled conditions to ensure stability.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Genetic counselling session to draw a family pedigree and discuss test benefits, risks, and limitations. Informed consent must be obtained.
2
During the Test:Non-invasive blood draw performed by a certified phlebotomist; sample sent to the lab for NGS analysis.
3
After the Test:Results are reviewed by a genetic specialist, and a report is generated. Genetic counselling is provided to interpret findings and discuss next steps.

About This Test

Who Should Get This Test

The purpose of this test is to identify mutations in the MMAA gene responsible for CblA type methylmalonic aciduria. It aids in confirming diagnosis, determining carrier status, facilitating genetic counselling, and informing treatment decisions for patients with suspected or confirmed MMA.

How to Prepare

  • Use sterile vacutainer tubes or FTA cards for sample collection
  • Label the sample with patient details accurately
  • Avoid hemolysis by gentle mixing and proper handling
  • Store blood samples at room temperature if not extracted DNA

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Early genetic testing for MMAA mutations can guide treatment and management for patients with methylmalonic aciduria, especially in families with a history of the disorder."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
ContainerVacutainer or FTA Card
Collection MethodVenipuncture or Finger prick

Sample Stability

Sample Rejection Criteria:
  • Hemolyzed or lipemic samples
  • Insufficient sample volume
  • Incorrect or missing patient labeling
  • Sample older than 48 hours for blood

Understanding Your Results

Results from the MMAA Gene NGS Genetic Test indicate the presence or absence of mutations in the MMAA gene. A positive result confirms a genetic predisposition to CblA type MMA, while a negative result suggests no detected mutations, but clinical correlation is advised.
📊

Normal (No pathogenic variants)

No mutations detected in the MMAA gene. Clinical symptoms may be due to other causes; further testing recommended.

📊

Abnormal (Pathogenic or Likely Pathogenic variant)

Mutation(s) detected consistent with CblA type MMA. This confirms genetic diagnosis and supports management planning.

📊

Variant of Uncertain Significance

A variant with unknown clinical significance. Genetic counselling and additional family studies may be needed for clarification.

⚠️ When to Consult a Doctor:

Consult a healthcare professional if the test results are positive, if symptoms persist despite negative results, or if there is a family history of methylmalonic aciduria. Genetic counselling is recommended for all patients and families.

Limitations

  • May not detect all types of mutations, such as large deletions or duplications
  • Does not rule out other causes of methylmalonic aciduria
  • Interpretation requires correlation with clinical symptoms and family history
  • Variants of uncertain significance may require further investigation

Risks & Considerations

  • Minimal risk from blood draw, such as bruising, soreness, or infection at the puncture site
  • No significant health risks associated with the genetic test itself
  • Psychological impact of results may require support and counselling

Interfering Factors

  • Sample contamination during collection or handling
  • Degraded DNA due to improper storage or transport
  • Previous blood transfusions affecting DNA quality
  • Presence of inhibitors in the sample

Compare With Similar Tests

TestMMAA Gene Methylmalonic aciduria CblA type NGS Genetic Test
ComparisonMMAA Gene Methylmalonic aciduria CblA type NGS Genetic Test

Frequently Asked Questions

What is the MMAA Gene Test?
It is a genetic test using NGS technology to detect mutations in the MMAA gene, which causes CblA type methylmalonic aciduria, a rare metabolic disorder.
Who should consider taking this test?
Individuals with symptoms like poor feeding, developmental delays, seizures, or a family history of methylmalonic aciduria should consider testing.
What are the symptoms of CblA type MMA?
Symptoms include poor feeding, vomiting, developmental delays, intellectual disability, enlarged liver and spleen, low muscle tone, seizures, and failure to thrive.
How is the test performed?
A blood sample is collected and analyzed using next-generation sequencing (NGS) to identify mutations in the MMAA gene.
What is the cost of the MMAA Gene Test?
The test costs INR 20000.0 in India, with free home sample collection available in many cities.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings across numerous cities in India.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
What do the results mean?
Results indicate the presence or absence of mutations. A positive result confirms genetic diagnosis; a negative result may require further investigation.
Is the test covered by insurance?
Coverage depends on your insurance policy. It is not typically covered under government schemes like PMJAY or CGHS; check with your provider.
Can this test detect all mutations causing MMA?
The test targets the MMAA gene specifically; it may not detect mutations in other genes like MMAB or MMUT that cause other types of MMA.
What is the difference between CblA and other types of MMA?
CblA type is caused by MMAA gene mutations, while other types like CblB or mut type involve different genes (e.g., MMAB, MMUT) and enzyme deficiencies.
How accurate is NGS testing for this condition?
NGS is highly accurate for detecting known mutations in the MMAA gene, with a detection rate of over 99% for targeted variants.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.